Therapeutic Innovation in Pancreatitis: Regenerative Medicine as a Pathway to Disease Modification

Abstract

Pancreatitis remains a major global health challenge and is characterized by complex inflammatory and fibrotic processes that progressively destroy the structural and functional integrity of the pancreas. Acute pancreatitis often begins as an abrupt inflammatory injury driven by premature enzyme activation, oxidative stress and immune dysregulation, which may lead to widespread tissue necrosis. Chronic pancreatitis develops gradually through persistent inflammation, activation of pancreatic stellate cells, excessive collagen deposition, ductal obstruction and loss of both digestive and hormone-producing cells. Current medical, nutritional, and endoscopic treatments provide symptomatic relief but do not reverse fibrosis, regenerate damaged tissue or restore pancreatic function. Regenerative medicine has emerged as a promising strategy capable of directly addressing the biological mechanisms responsible for pancreatic injury. Stem cell–based therapies, induced pluripotent stem cell–derived replacements, engineered extracellular vesicles, gene-modifying technologies, organoid systems, and bioengineered scaffolds demonstrate the potential to reduce inflammation, inhibit fibrotic remodeling, enhance vascular repair and restore exocrine and endocrine cell populations. Preclinical studies consistently show improvements in pancreatic architecture, enzyme secretion, microvascular stability and hormone regulation following regenerative interventions. However, translation into clinical practice remains limited by challenges such as poor survival of transplanted cells within fibrotic tissue, immature differentiation of engineered cells, insufficient blood vessel formation in engineered constructs, variable manufacturing quality and the lack of well-designed human trials. Despite these limitations, ongoing scientific advances suggest that regenerative medicine may ultimately provide the first disease-modifying treatment capable of restoring pancreatic structure and function.